Cirurgia geral
Manejo da anemia pós-operatória
Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (abre nova janela)
Fonte: Pharmacotherapy 2008;28(11):1383-90.
Indexado: PubMed 18956998
DOI: 10.1592/phco.28.11.1383
https://www.ncbi.nlm.nih.gov/pubmed/18956998 (abre nova janela)
Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (abre nova janela)
Fonte: Transplant Proc 2015;47(8):2548-51.
Indexado: PubMed 26518969
DOI: 10.1016/j.transproceed.2015.09.014
https://www.ncbi.nlm.nih.gov/pubmed/26518969 (abre nova janela)
Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (abre nova janela)
Fonte: Lancet Haematol 2016;3(9):e415-25.
Indexado: PubMed 27570088
DOI: 10.1016/S2352-3026(16)30078-3
https://www.ncbi.nlm.nih.gov/pubmed/27570088 (abre nova janela)
How do we treat life-threatening anemia in a Jehovah's Witness patient? (abre nova janela)
Fonte: Transfusion 2014;54(12):3026-34.
Indexado: PubMed 25330835
DOI: 10.1111/trf.12888
https://www.ncbi.nlm.nih.gov/pubmed/25330835 (abre nova janela)
Transfusion-free management of gastrointestinal bleeding: the experience of a Bloodless Institute. (abre nova janela)
Fonte: J Clin Gastroenterol 2015;49(3):206-11.
Indexado: PubMed 25144897
DOI: 10.1097/MCG.0000000000000200
https://www.ncbi.nlm.nih.gov/pubmed/25144897 (abre nova janela)